DK137392C - Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination - Google Patents

Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Info

Publication number
DK137392C
DK137392C DK447972A DK447972A DK137392C DK 137392 C DK137392 C DK 137392C DK 447972 A DK447972 A DK 447972A DK 447972 A DK447972 A DK 447972A DK 137392 C DK137392 C DK 137392C
Authority
DK
Denmark
Prior art keywords
prevaccination
vira
copd
vaccinia
vaccination
Prior art date
Application number
DK447972A
Other languages
Danish (da)
English (en)
Other versions
DK137392B (da
Inventor
A H Stickl
Original Assignee
Bayern Freistaat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by Bayern Freistaat filed Critical Bayern Freistaat
Publication of DK137392B publication Critical patent/DK137392B/da
Application granted granted Critical
Publication of DK137392C publication Critical patent/DK137392C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK447972A 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination DK137392C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (2)

Publication Number Publication Date
DK137392B DK137392B (da) 1978-02-27
DK137392C true DK137392C (da) 1978-09-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447972A DK137392C (da) 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Country Status (5)

Country Link
AT (1) AT320149B (fr)
BE (1) BE787901A (fr)
CH (1) CH568392A5 (fr)
DK (1) DK137392C (fr)
ES (1) ES406590A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (fr) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Virus recombinant de la vaccine derive du virus modifie ankara
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
WO2004015118A1 (fr) 2002-08-07 2004-02-19 Bavarian Nordic A/S Genes hotes du virus de la vaccine permettant d'augmenter le titre de l'avipoxvirus
CA2520637A1 (fr) 2003-03-28 2004-10-14 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Mva exprimant des genes modifies enveloppe, gag et pol du vih
ES2539010T3 (es) 2004-08-27 2015-06-25 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Virus MVA recombinantes que expresan genes env, gag y pol modificados de VIH clado A/G, clado B, y clado C
AU2008250596C1 (en) 2007-05-14 2010-11-25 Bavarian Nordic A/S Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
US20120135032A1 (en) 2009-10-08 2012-05-31 Bavarian Nordic A/S Generation of a broad t-cell response in humans against hiv
NZ603620A (en) 2010-07-20 2015-01-30 Bavarian Nordic As Method for harvesting expression products
EP2620446A1 (fr) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogènes pour la vaccination contre le VIH
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
PL3402802T3 (pl) 2016-01-08 2023-06-05 Geovax, Inc. Kompozycje i sposoby generowania odpowiedzi immunologicznej względem antygenu powiązanego z guzem nowotworowym
US11666651B2 (en) 2019-11-14 2023-06-06 Aelix Therapeutics, S.L. Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
WO2021260065A1 (fr) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Vaccin à base de mva contre la covid-19 exprimant des antigènes de sras-cov-2
EP3928789A1 (fr) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Vaccin à base de mva contre le covid-19 exprimant les antigènes du sars-cov-2
EP4108257A1 (fr) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Vaccin à base du virus de la vaccine ankara (mva) contre la covid-19 exprimant une protéine sars-cov-2 s stabilisée dans une préfusion
WO2022269003A1 (fr) 2021-06-23 2022-12-29 Consejo Superior De Investigaciones Cientificas Vaccin à base de mva exprimant une protéine s du sars-cov-2 stabilisée par préfusion

Also Published As

Publication number Publication date
DE2145477A1 (de) 1973-03-15
ES406590A1 (es) 1975-09-16
DE2145477B2 (de) 1976-04-01
DK137392B (da) 1978-02-27
CH568392A5 (fr) 1975-10-31
BE787901A (fr) 1972-12-18
AT320149B (de) 1975-01-27

Similar Documents

Publication Publication Date Title
DK137392C (da) Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination
DK114429B (da) Fremsgangmåde til fremstilling af et med kontrolleret frigørelse virkende terapeutisk præparat til oral brug.
DK131891C (da) Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
DK138695C (da) Fremgangsmaade til fremstilling af pyrrolidon-5,5-difosfonsyrer og vandoploeselige salte heraf
DK132321C (da) Analogifremgangsmade til fremstilling af usymmetriske 1,4-dihydropyridiner
AR193737A1 (es) Composicion glaseadora a base de fluoruro para esmalte dental
DK401575A (da) Cis-decahydroisoquinolin-analgetika og fremgangsmade til deres fremstilling
IT1048942B (it) Procedimento per la preparazione di estratti di spezie aventi una composizione naturale
AR200895A1 (es) Procedimiento para preparar una vacuna de virus vivos respiratorios bovinos
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
DK135040C (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridiner
ZA755043B (en) Enteric disease vaccine
DK133018C (da) Fremgangsmade til fremstilling af en drebt vaccine mod infektios atrofisk rhinitis hos svin
DK132204B (da) Præparat til sætning af hår.
BE781028R (fr) Adjuvants pour vaccins et preparations de vaccins les
DK114644B (da) Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.
IT966747B (it) Procedimento per preparare dinitroantrachinoni
DK136778B (da) Fremgangsmade til fremstilling af aminholdige preparater af disazopigmenter af 3,3-dichlorbenzidinrekken
DK139521C (da) Fremgangsmaade til fremstilling af ren krystallinsk penicillinacylase
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
DK141055C (da) Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis
SE424503B (sv) Forfarande for framstellning av levande influensavirusvaccin typ b
IT1101491B (it) Vaccino anti-tiro e procedimento per la sua preparazione
IT974827B (it) Procedimento per preparare fosfo noticati sostituiti